Cellectis S.A.
CLLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5,397.5% | -96.1% | -36.8% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 77.9% | -882.6% | 55.7% | 93.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -22.8% | -12,269.8% | -398.4% | -258.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -88.6% | -13,385.3% | -553.6% | -376.3% |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.93 |
| % Growth | 76.8% | 24% | -20.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |